Clinical Trial Update: Bevacizumab, Oxaliplatin, and Docetaxel in Treating Patients With Locally Advanced Unresectable or Metastatic Stomach or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab, oxaliplatin, and docetaxel for locally advanced unresectable or metastatic stomach or gastroesophageal junction c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastric Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Esophageal Cancer, Gastric Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-07-07